In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia. [PDF]
Romano A +3 more
europepmc +1 more source
Spatial-spectral fusion enables drug repositioning by capturing indirect and long-range associations in biological networks. [PDF]
Zhu X +8 more
europepmc +1 more source
Integrated Approaches in Drug Repositioning Highlight Ouabain and Helenalin as Potential Drug Candidates for Pulmonary Fibrosis. [PDF]
Al-Abdulraheem Z +9 more
europepmc +1 more source
Review on drug repositioning of some FDA-approved drugs for treatment of cancer/microbial diseases. [PDF]
Ismail MMF +4 more
europepmc +1 more source
When Side Effects Become Therapies: A Mechanistic Taxonomy of Adverse Drug Reactions as Translational Signals for Drug Repositioning. [PDF]
Emanuele E +6 more
europepmc +1 more source
Machine Learning-Driven Drug Repositioning Identifies Putative IRAK4 Inhibitors Through Structure-Based Computational Evaluation. [PDF]
Na H, Park J, Choi J.
europepmc +1 more source
Link Prediction in Multipartite Graphs With Application to Drug Repositioning Studies. [PDF]
Chen C +4 more
europepmc +1 more source
Unlocking new therapeutic horizons through integrative bioinformatics and transcriptomics for drug repositioning in breast cancer therapy. [PDF]
Adikusuma W +6 more
europepmc +1 more source
A fused deep learning approach to transform drug repositioning. [PDF]
Li K +9 more
europepmc +1 more source
Drug Repositioning in Doxorubicin-Induced Cardiotoxicity Protection. [PDF]
Kosić M +3 more
europepmc +1 more source

